美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Retension Pharmaceuticals Inc

11.32

+0.79007.50%

盘后：11.620.2975+2.63%19:55 EDT

成交量：17.76万

成交额：199.68万

市值：8,921.97万

市盈率：-7.47

高：11.79

开：10.88

低：10.16

收：10.53

52周最高：11.79

52周最低：9.66

股本：788.16万

流通股本：666.00万

量比：0.23

换手率：2.67%

股息：- -

股息率：- -

每股收益(TTM):-1.5150

每股收益(LYR):-1.7211

净资产收益率：--

总资产收益率：--

市净率：-5.98

市盈率(LYR):-6.58

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Retension Pharmaceuticals Inc

交易所：

NASDAQ

成立时间：

2023

员工人数：

12

公司地址：

1104 West Broad Street,Suite 1029,Falls Church,Virginia,United States

官网：

http://www.retensionpharmaceuticals.com;www.retensionpharma.com

邮编：

22046

电话：

传真：

- -

简介：

Retension Pharmaceuticals, Inc.于2023年7月26日在特拉华州注册成立，总部位于弗吉尼亚州福尔斯彻奇。该公司是一家临床阶段的生物制药公司，专注于开发治疗高血压和其他心血管疾病的药物。其候选产品RTN-001是一种下一代、每日一次的口服小分子PDE-5抑制剂，旨在通过增强一氧化氮信号传导来降低血压，目前正在开发用于未控制的高血压和耐药性高血压患者。

董事

名称

职位

Eric Keller

Chief Executive Officer and Director

Michael Joseph Berendt

Director and Chairman of the Board

Donald Olds

Director

Franklin M. Berger

Director

股东

名称

职位

Eric Keller

Chief Executive Officer and Director

Sabine Bisson

Chief Operating Officer

Alex Schwartz

Chief Financial Officer

Alison D. Schecter

Chief Medical Officer

Paul Sweetnam

Chief Scientific Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/RTSN/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RTSN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTSN\",,,,,undefined,":{"symbol":"RTSN","market":"US","secType":"STK","nameCN":"Retension Pharmaceuticals Inc","latestPrice":11.32,"timestamp":1791835200000,"preClose":10.53,"halted":0,"volume":177617,"hourTrading":{"tag":"盘后","latestPrice":11.6175,"preClose":11.32,"latestTime":"19:55 EDT","volume":5451,"amount":63775.2224,"timestamp":1791849313435,"change":0.2975,"changeRate":0.026281,"amplitude":0.121095},"delay":0,"changeRate":0.07502374169040844,"floatShares":6659951,"shares":7881599,"eps":-1.515,"marketStatus":"已收盘","change":0.79,"latestTime":"10-12 16:00:00 EDT","open":10.88,"high":11.79,"low":10.16,"amount":1996766.9392769998,"amplitude":0.154796,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.515,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791878400000},"marketStatusCode":5,"adr":0,"listingDate":1791518400000,"exchange":"NASDAQ","adjPreClose":10.53,"preHourTrading":{"tag":"盘前","latestPrice":10.79,"preClose":10.53,"latestTime":"09:29 EDT","volume":793,"amount":8273.610072,"timestamp":1791811769010,"change":0.26,"changeRate":0.024691,"amplitude":0.072175},"postHourTrading":{"tag":"盘后","latestPrice":11.6175,"preClose":11.32,"latestTime":"19:55 EDT","volume":5451,"amount":63775.2224,"timestamp":1791849313435,"change":0.2975,"changeRate":0.026281,"amplitude":0.121095},"volumeRatio":0.225058},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTSN\",,,,,undefined,":{"symbol":"RTSN","floatShares":6659951,"roa":"--","roe":"--","lyrEps":-1.721059,"volumeRatio":0.225058,"shares":7881599,"dividePrice":0,"high":11.79,"amplitude":0.154796,"preClose":10.53,"low":10.16,"week52Low":9.66,"pbRate":"-5.98","week52High":11.79,"institutionHeld":0,"latestPrice":11.32,"eps":-1.515,"divideRate":0,"volume":177617,"delay":0,"ttmEps":-1.515,"open":10.88,"prevYearClose":12,"prevWeekClose":10.53,"prevMonthClose":12,"prevQuarterClose":12,"fiveDayClose":12,"twentyDayClose":12,"sixtyDayClose":12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RTSN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RTSN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RTSN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RTSN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RTSN","date":"2026-10-09","current":-7.471947,"percent":1,"low":-7.018706,"twenty":-7.018706,"median":-7.018706,"eighty":-7.018706,"high":-7.018706,"avg":-7.018706,"sd":0,"marketCap":99979188},"quantilePoints":[{"date":"2026-10-09","current":-7.018706,"twenty":-7.018706,"median":-7.018706,"eighty":-7.018706,"marketCap":99979188}],"updateTime":1791852523005},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1863887795,"yearFounded":2023,"employeeNum":12,"address":"1104 West Broad Street,Suite 1029,Falls Church,Virginia,United States","zipCode":"22046","officePhone":"(703) 940-9761","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.retensionpharmaceuticals.com;www.retensionpharma.com","stockEarnings":[{"period":"1week","weight":-0.1225},{"period":"ytd","weight":-0.1225}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.0313},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1417}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Retension Pharmaceuticals, Inc.于2023年7月26日在特拉华州注册成立，总部位于弗吉尼亚州福尔斯彻奇。该公司是一家临床阶段的生物制药公司，专注于开发治疗高血压和其他心血管疾病的药物。其候选产品RTN-001是一种下一代、每日一次的口服小分子PDE-5抑制剂，旨在通过增强一氧化氮信号传导来降低血压，目前正在开发用于未控制的高血压和耐药性高血压患者。","exchange":"NASDAQ","name":"Retension Pharmaceuticals Inc","nameEN":"Retension Pharmaceuticals Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RTSN\",market:\"US\",,,undefined,":{"directors":[{"name":"Eric Keller","position":"Chief Executive Officer and Director"},{"name":"Michael Joseph Berendt","position":"Director and Chairman of the Board"},{"name":"Donald Olds","position":"Director"},{"name":"Franklin M. Berger","position":"Director"}],"executives":[{"name":"Eric Keller","position":"Chief Executive Officer and Director"},{"name":"Sabine Bisson","position":"Chief Operating Officer"},{"name":"Alex Schwartz","position":"Chief Financial Officer"},{"name":"Alison D. Schecter","position":"Chief Medical Officer"},{"name":"Paul Sweetnam","position":"Chief Scientific Officer"}]}}}